Ambu, a medical device maker with U.S. headquarters in Columbia, has won federal approval to sell a new generation of single-use bronchoscopes after demand for such products increased during the pandemic. Regulatory clearance from the U.S. Food and Drug Administration will allow the Danish company to commercialize its new bronchosope products, which come with advanced imaging and design features, including a new high-resolution camera chip, the company said.
Columbia-based medical device maker wins FDA approval to sell upgraded single-use bronchoscopes
July 29, 2022